{"url":"https://lda.senate.gov/api/v1/filings/29681fa5-e3e2-41f8-9854-3bbf05a2a089/","filing_uuid":"29681fa5-e3e2-41f8-9854-3bbf05a2a089","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/29681fa5-e3e2-41f8-9854-3bbf05a2a089/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Vicki Iseman","dt_posted":"2025-09-03T15:48:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1100 North Glebe Rd","registrant_address_2":"1010","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22201","registrant":{"id":401103582,"url":"https://lda.senate.gov/api/v1/registrants/401103582/","house_registrant_id":null,"name":"ISEMAN & ASSOCIATES LLC","description":"Government Affairs","address_1":"700 S Rosemary Ave","address_2":"Unit 204","address_3":null,"address_4":null,"city":"West Palm Beach","state":"FL","state_display":"Florida","zip":"33401","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"VICKI ISEMAN","contact_telephone":"+1 703-258-1366","dt_updated":"2026-01-26T14:26:25.502288-05:00"},"client":{"id":199655,"url":"https://lda.senate.gov/api/v1/clients/199655/","client_id":90,"name":"TICHENOR VENTURES, LLC","general_description":"Biotechnology","client_government_entity":false,"client_self_select":null,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-06-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Monitoring biotech legislation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61689,"prefix":null,"prefix_display":null,"first_name":"VICKI","nickname":null,"middle_name":null,"last_name":"ISEMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70301,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"LOEBER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Monitoring biotech legislation; prescription drug prices","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61689,"prefix":null,"prefix_display":null,"first_name":"VICKI","nickname":null,"middle_name":null,"last_name":"ISEMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70301,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"LOEBER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AVI","general_issue_code_display":"Aviation/Airlines/Airports","description":"Monitoring the FAA Reauthorization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61689,"prefix":null,"prefix_display":null,"first_name":"VICKI","nickname":null,"middle_name":null,"last_name":"ISEMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70301,"prefix":null,"prefix_display":null,"first_name":"KYLE","nickname":null,"middle_name":null,"last_name":"LOEBER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}